The latest effort to make healthy women believe they are ill is a new movie on perimenopause, “The M Factor 2: Before the Pause,” which debuted...
Biopharma funding fell 20% last year, reversing the post-pandemic recovery as the IPO haul dropped to the lowest level of the past 10 years, according to...
Snow flies have an unexpected way of surviving freezing temperatures. They produce antifreeze proteins to block ice formation and can even generate their own heat. Scientists...
Innate Pharma has finally called time on a NK cell engager in phase 1/2 development as part of an ongoing fine-tuning of the French biotech’s pipeline.
There is no end in sight for the Centers for Disease Control and Prevention’s leadership limbo, with the Trump administration confirming on Wednesday it would not...
Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, the companies said today, in a deal designed to bolster the buyer’s cancer...
Modern medicine has achieved extraordinary success in treating acute disease. Yet when it comes to chronic degenerative conditions, the diseases that dominate healthcare spending and disability...
Anyone who has weathered a bad stomach bug knows the feeling: a loss of appetite that sets in and lingers, even after the initial illness. For...
It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a...
Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney disease.